These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36601501)

  • 21. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
    Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
    Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
    Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
    BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
    Malfará M; Pernassi M; Aragon D; Carlotti A
    Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
    Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
    Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
    Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
    Chen CC; Hsiao FY; Shen LJ; Wu CC
    Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
    Chen PZ; Wu CC; Huang CF
    J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
    Hamblin S; Rumbaugh K; Miller R
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital.
    Amir M; Zehra A; Munawar R; Gul W; Fatima T; Khan Y; Jaffery R; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):533-539. PubMed ID: 38362677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
    Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
    Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of expanded use of clinical pharmacist practitioners in addition to team-based care in a community health system intensive care unit.
    Michalets E; Creger J; Shillinglaw WR
    Am J Health Syst Pharm; 2015 Jan; 72(1):47-53. PubMed ID: 25511838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
    Kim HJ; Lee S; Lee YJ; Kim S; Jo YH; Cho YS; An HY; Hong KT; Choi JY; Kang HJ; Shin HY; Lee JY
    J Oncol Pharm Pract; 2023 Mar; 29(2):319-325. PubMed ID: 34931912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital.
    Zaidi ST; Hassan Y; Postma MJ; Ng SH
    Pharm World Sci; 2003 Dec; 25(6):299-302. PubMed ID: 14689820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
    Gallagher J; Byrne S; Woods N; Lynch D; McCarthy S
    BMC Health Serv Res; 2014 Apr; 14():177. PubMed ID: 24742158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy.
    Lombardi N; Wei L; Ghaleb M; Pasut E; Leschiutta S; Rossi P; Troncon MG
    BMC Health Serv Res; 2018 Apr; 18(1):259. PubMed ID: 29631587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
    Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
    Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.